IPSC
Century Therapeutics, Inc.$2.19-0.06 (-2.67%)Prev Close$2.25·MCap$194.8M·P/E—·Vol404.6K·Yield—
▲
Buys (12M)
3
$96.9K
▼
Sells (12M)
21
$139.7K
◆
Net Activity
Net Seller
$42.8K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Century Therapeutics, Inc. (IPSC) has been mixed between buying and selling, with 3 insider purchases totaling $96.9K and 21 insider sales totaling $139.7K. The most recent insider transaction was by Carr Douglas (officer: SVP Finance & Operations), who sold $18.0K worth of shares on Mar 16, 2026. Century Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $194.8M.
IPSC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Carr Douglas | officer: SVP Finance & Operations | Sell | 7,043 | $2.55 | $18.0K | 507,261 |
| Mar 16, 2026 | Russotti Gregory | officer: See Remarks | Sell | 10,076 | $2.55 | $25.7K | 515,427 |
| Mar 11, 2026 | Russotti Gregory | officer: See Remarks | Sell | 479 | $2.54 | $1.2K | 525,503 |
| Feb 18, 2026 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $1.75 | $54.6K | 0 |
| Feb 5, 2026 | Carr Douglas | officer: SVP Finance & Operations | Sell | 323 | $1.82 | $588.51 | 514,551 |
| Dec 29, 2025 | Cowan Chad | Chief Scientific Officer | Buy | 58,060 | $0.85 | $49.3K | 1,045,087 |
| Dec 16, 2025 | Pfeiffenberger Brent | President and CEO | Buy | 52,000 | $0.58 | $30.4K | 3,322,990 |
| Dec 10, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 257 | $0.53 | $136.72 | 404,874 |
| Dec 10, 2025 | Russotti Gregory | See Remarks | Sell | 526 | $0.53 | $279.83 | 390,982 |
| Nov 24, 2025 | Cowan Chad | Chief Scientific Officer | Sell | 5,462 | $0.50 | $2.7K | 987,027 |
| Nov 20, 2025 | Pfeiffenberger Brent | President and CEO | Buy | 35,000 | $0.50 | $17.3K | 3,271,453 |
| Nov 19, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 32,456 | $0.45 | $14.7K | 3,236,453 |
| Nov 5, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 292 | $0.59 | $171.11 | 405,131 |
| Sep 10, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 263 | $0.50 | $131.50 | 405,423 |
| Sep 10, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 488 | $0.50 | $244.00 | 3,268,909 |
| Sep 10, 2025 | Russotti Gregory | See Remarks | Sell | 539 | $0.50 | $269.50 | 391,508 |
| Aug 6, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 296 | $0.53 | $158.06 | 405,686 |
| Jun 11, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 4,904 | $0.62 | $3.1K | 405,982 |
| Jun 11, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 552 | $0.62 | $343.34 | 250,141 |
| Jun 11, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 475 | $0.62 | $295.45 | 1,681,783 |
| Jun 11, 2025 | Russotti Gregory | See Remarks | Sell | 526 | $0.62 | $327.17 | 392,047 |
| May 20, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 29,552 | $0.55 | $16.1K | 1,682,258 |
| May 7, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 295 | $0.55 | $162.25 | 410,886 |
| May 7, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 1,024 | $0.55 | $563.20 | 250,693 |
| Mar 12, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 1,240 | $0.62 | $762.60 | 315,556 |
| Mar 12, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 2,359 | $0.62 | $1.5K | 131,717 |
| Mar 12, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 2,235 | $0.62 | $1.4K | 1,190,310 |
| Mar 12, 2025 | Russotti Gregory | See Remarks | Sell | 2,360 | $0.62 | $1.5K | 272,573 |
| Feb 20, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 34,712 | $0.78 | $27.2K | 1,192,545 |
| Feb 5, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 351 | $0.78 | $273.78 | 316,796 |
| Feb 5, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 1,054 | $0.78 | $822.12 | 134,076 |
| Nov 5, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 283 | $1.23 | $347.24 | 317,147 |
| Nov 5, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 1,033 | $1.23 | $1.3K | 135,130 |
| Sep 16, 2024 | Quimi Daphne | Director | Buy | 5,000 | $1.53 | $7.7K | 5,000 |
| Aug 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 289 | $1.83 | $528.00 | 334,041 |
| Aug 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 1,073 | $1.83 | $2.0K | 136,163 |
| Jul 31, 2024 | Russotti Gregory | See Remarks | Sell | 586 | $2.50 | $1.5K | 274,933 |
| Jul 25, 2024 | Russotti Gregory | See Remarks | Sell | 1,800 | $2.52 | $4.5K | 277,119 |
| Jun 24, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $2.84 | $14.2K | 277,319 |
| Jun 6, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 282,319 |
| May 21, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 287,319 |
| May 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 257 | $3.11 | $798.24 | 317,323 |
| May 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 913 | $3.11 | $2.8K | 137,236 |
| May 7, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.12 | $15.6K | 292,319 |
| Apr 24, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.10 | $15.5K | 297,319 |
| Mar 8, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 53,515 | $5.04 | $269.7K | 114,149-32% |
| Feb 21, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 485 | $4.86 | $2.4K | 114,149 |
| Feb 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 1,200 | $4.14 | $5.0K | 304,137 |
| Feb 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 3,819 | $4.14 | $15.8K | 115,933 |
| Mar 23, 2023 | Borges Luis | Chief Scientific Officer | Sell | 144,911 | $3.73 | $539.9K | 249,083-37% |
Showing 1–50 of 54
1 / 2
IPSC Insider Buying Activity
The following table shows recent insider purchases of Century Therapeutics, Inc. (IPSC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Cowan Chad | Chief Scientific Officer | Buy | 58,060 | $0.85 | $49.3K | 1,045,087 |
| Dec 16, 2025 | Pfeiffenberger Brent | President and CEO | Buy | 52,000 | $0.58 | $30.4K | 3,322,990 |
| Nov 20, 2025 | Pfeiffenberger Brent | President and CEO | Buy | 35,000 | $0.50 | $17.3K | 3,271,453 |
| Sep 16, 2024 | Quimi Daphne | Director | Buy | 5,000 | $1.53 | $7.7K | 5,000 |
IPSC Insider Selling Activity
The following table shows recent insider sales of Century Therapeutics, Inc. (IPSC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Carr Douglas | officer: SVP Finance & Operations | Sell | 7,043 | $2.55 | $18.0K | 507,261 |
| Mar 16, 2026 | Russotti Gregory | officer: See Remarks | Sell | 10,076 | $2.55 | $25.7K | 515,427 |
| Mar 11, 2026 | Russotti Gregory | officer: See Remarks | Sell | 479 | $2.54 | $1.2K | 525,503 |
| Feb 18, 2026 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $1.75 | $54.6K | 0 |
| Feb 5, 2026 | Carr Douglas | officer: SVP Finance & Operations | Sell | 323 | $1.82 | $588.51 | 514,551 |
| Dec 10, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 257 | $0.53 | $136.72 | 404,874 |
| Dec 10, 2025 | Russotti Gregory | See Remarks | Sell | 526 | $0.53 | $279.83 | 390,982 |
| Nov 24, 2025 | Cowan Chad | Chief Scientific Officer | Sell | 5,462 | $0.50 | $2.7K | 987,027 |
| Nov 19, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 32,456 | $0.45 | $14.7K | 3,236,453 |
| Nov 5, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 292 | $0.59 | $171.11 | 405,131 |
| Sep 10, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 263 | $0.50 | $131.50 | 405,423 |
| Sep 10, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 488 | $0.50 | $244.00 | 3,268,909 |
| Sep 10, 2025 | Russotti Gregory | See Remarks | Sell | 539 | $0.50 | $269.50 | 391,508 |
| Aug 6, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 296 | $0.53 | $158.06 | 405,686 |
| Jun 11, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 4,904 | $0.62 | $3.1K | 405,982 |
| Jun 11, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 552 | $0.62 | $343.34 | 250,141 |
| Jun 11, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 475 | $0.62 | $295.45 | 1,681,783 |
| Jun 11, 2025 | Russotti Gregory | See Remarks | Sell | 526 | $0.62 | $327.17 | 392,047 |
| May 20, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 29,552 | $0.55 | $16.1K | 1,682,258 |
| May 7, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 295 | $0.55 | $162.25 | 410,886 |
| May 7, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 1,024 | $0.55 | $563.20 | 250,693 |
| Mar 12, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 1,240 | $0.62 | $762.60 | 315,556 |
| Mar 12, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 2,359 | $0.62 | $1.5K | 131,717 |
| Mar 12, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 2,235 | $0.62 | $1.4K | 1,190,310 |
| Mar 12, 2025 | Russotti Gregory | See Remarks | Sell | 2,360 | $0.62 | $1.5K | 272,573 |
| Feb 20, 2025 | Pfeiffenberger Brent | President and CEO | Sell | 34,712 | $0.78 | $27.2K | 1,192,545 |
| Feb 5, 2025 | Carr Douglas | SVP Finance & Operations | Sell | 351 | $0.78 | $273.78 | 316,796 |
| Feb 5, 2025 | Farid Adrienne | Chief Operations Officer | Sell | 1,054 | $0.78 | $822.12 | 134,076 |
| Nov 5, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 283 | $1.23 | $347.24 | 317,147 |
| Nov 5, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 1,033 | $1.23 | $1.3K | 135,130 |
| Aug 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 289 | $1.83 | $528.00 | 334,041 |
| Aug 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 1,073 | $1.83 | $2.0K | 136,163 |
| Jul 31, 2024 | Russotti Gregory | See Remarks | Sell | 586 | $2.50 | $1.5K | 274,933 |
| Jul 25, 2024 | Russotti Gregory | See Remarks | Sell | 1,800 | $2.52 | $4.5K | 277,119 |
| Jun 24, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $2.84 | $14.2K | 277,319 |
| Jun 6, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 282,319 |
| May 21, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 287,319 |
| May 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 257 | $3.11 | $798.24 | 317,323 |
| May 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 913 | $3.11 | $2.8K | 137,236 |
| May 7, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.12 | $15.6K | 292,319 |
| Apr 24, 2024 | Russotti Gregory | See Remarks | Sell | 5,000 | $3.10 | $15.5K | 297,319 |
| Mar 8, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 53,515 | $5.04 | $269.7K | 114,149-32% |
| Feb 21, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 485 | $4.86 | $2.4K | 114,149 |
| Feb 7, 2024 | Carr Douglas | SVP Finance & Operations | Sell | 1,200 | $4.14 | $5.0K | 304,137 |
| Feb 7, 2024 | Farid Adrienne | Chief Operations Officer | Sell | 3,819 | $4.14 | $15.8K | 115,933 |
| Mar 23, 2023 | Borges Luis | Chief Scientific Officer | Sell | 144,911 | $3.73 | $539.9K | 249,083-37% |
IPSC Insiders
Similar Stocks to IPSC
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B